Venous Therapies

This channel includes news and new technology innovations of Venous Therapies including deep vein thrombosis (DVT) and vena cava filters.

The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).

The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).

Feature | Antiplatelet and Anticoagulation Therapies | December 27, 2019

December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics...

The ClotTriever system (Inari Medical), a mechanical thrombectomy system FDA 510(k) cleared for the nonsurgical removal of soft thrombi and emboli from peripheral blood vessels.  #VIVA19 #VIVA2019

The ClotTriever system (Inari Medical), a mechanical thrombectomy system FDA 510(k) cleared for the nonsurgical removal of soft thrombi and emboli from peripheral blood vessels. 

 

News | Deep Vein Thrombosis (DVT) | November 14, 2019

November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following...

A comparison of intravascular ultrasound (IVUS) vs. angiography found a significant mismatch and showed the benefits of IVUS in venous interventions.

A comparison of intravascular ultrasound (IVUS) vs. angiography found a significant mismatch and showed the benefits of IVUS in venous interventions.

News | Venous Therapies | October 31, 2019

October 31, 2019 – In a large series of iliac vein stent cases, a blinded comparison found...

New Study Visually Tracks Chronic Venous Insufficiency Wound Healing in EMR
News | Electronic Medical Records (EMR) | August 13, 2019

August 13, 2019 — A simple change in the way health professionals track their patients’ progress has brought...

Fragmin (dalteparin sodium) injection was cleared by the FDA for use in pediatric patients. It was initially approved by the FDA in 1994 for adults and is a type of heparin.

Fragmin (dalteparin sodium) injection is now cleared by the FDA for use in pediatric patients. It was initially approved by the FDA in 1994 for adults and is a type of heparin.

Technology | Antiplatelet and Anticoagulation Therapies | May 17, 2019

May 17, 2019 — The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection...

Illustration showing the self-expanding deployment of the Boston Scientific Vici venous stent in the iliofemoral vein.

Illustration showing the self-expanding deployment of the Vici stent in the iliofemoral vein. 

Technology | Venous Therapies | May 06, 2019

May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System...

The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous Stent System intended to treat narrowed iliofemoral veins.
Technology | Venous Therapies | April 03, 2019

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo...

JETi Thrombectomy System Safe and Effective for Deep Vein Thrombosis
News | Thrombectomy Devices | February 12, 2019

February 12, 2019 — A study presented at the 2018 annual meeting of the Cardiovascular and Interventional Radiology...

An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal. Thrombectomy is also referred to as embolectomy.

An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal.

Feature | Thrombectomy Devices | January 22, 2019 | Dave Fornell, Editor

Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but...

First BTG Sentry Bioconvertible IVC Filter Implanted in U.S.
News | Vena Cava Filters | December 04, 2018

December 4, 2018 — BTG plc announced the first patients outside of a clinical trial have been successfully implanted...

First Commercial Ekos Control Unit 4.0 Products Shipped to Europe
News | Thrombectomy Devices | November 21, 2018

November 21, 2018 — BTG plc announced the first Ekos CU 4.0 units have been shipped from BTG’s facility in Bothell,...

News | Venous Therapies | August 08, 2018

August 8, 2018 — Boston Scientific Corp. announced it has signed an agreement to...

A patient case study showing a venous ulcer formation 18 months following thermal ablation varicose vein treatment in the GSV. The patient was treated with Varithena polidocanol endovenous microfoam chemical-ablation. Images show baseline prior to treatment (right), followed by one, four and six weeks after treatment. The treatment is also called sclerotherapy.

A patient case study showing a venous ulcer formation 18 months following thermal ablation varicose vein treatment in the GSV. The patient was treated with Varithena polidocanol endovenous microfoam chemical-ablation. Images show baseline prior to treatment (right), followed by one, four and six weeks after treatment.

Feature | Venous Therapies | April 30, 2018 | Tif Siragusa, M.D.

The introduction of thermal ablation revolutionized the treatment of varicose veins, yet recurrence remains a...

Vascade Vascular Closure System Approved for Femoral Vein Closure
Technology | Vascular Closure Devices | April 10, 2018

April 10, 2018 – Cardiva Medical announced the company received U.S. Food and Drug Administration (FDA) approval for...

Illustration of the EkoSonic catheter aiding drug-dispersion in a DVT clot. Catheter directed thrombolysis of deep vein thrombosis.

Illustration of the EkoSonic catheter aiding drug-dispersion in a DVT clot.

Feature | Deep Vein Thrombosis (DVT) | February 16, 2018 | Sanjay Pandya, M.D.

There are few downsides to using tibial venous access to treat...

Overlay Init